Trump’s latest tariff move arrives as a social-media surprise, with a 100% duty on branded or patented pharmaceutical products entering the United States unless manufacturers are building or planning to build US facilities. The post, made on Truth Social, did not include formal legislation, leaving industry and investors to parse what such a policy would…